rs75549581
|
|
|
0.810 |
GeneticVariation |
BEFREE |
An interesting fact is that A559T was so far found mostly in CF patients of African-American origin.
|
10653145 |
2000 |
rs74551128
|
|
|
0.880 |
GeneticVariation |
BEFREE |
Analysis of cystic fibrosis-associated missense mutations in the first nucleotide binding domain (NBD1), including A455E, S549R, Y563N, and P574H, revealed reduced levels of mature CFTR with elevated levels of carboxyl-terminal polypeptide fragments of 105 and 90 kDa.
|
10764788 |
2000 |
rs121908758
|
|
|
0.830 |
GeneticVariation |
BEFREE |
Analysis of cystic fibrosis-associated missense mutations in the first nucleotide binding domain (NBD1), including A455E, S549R, Y563N, and P574H, revealed reduced levels of mature CFTR with elevated levels of carboxyl-terminal polypeptide fragments of 105 and 90 kDa.
|
10764788 |
2000 |
rs213950
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Analysis of intron 8 (TG)mTn and M470V polymorphic loci did not permit the characterization of the CFTR dysfunction underlying the CF phenotype in the patients for which no CFTR mutation was identified.
|
17020467 |
2006 |
rs121909047
|
|
|
0.810 |
GeneticVariation |
BEFREE |
As it is the case for F508del-CFTR (the most common CF mutant), low temperature treatment partially rescues a functional A561E-CFTR channel, suggesting that substitution of glutamic acid for alanine at position 561 does not completely abolish CFTR function.
|
14623323 |
2003 |
rs1057516619
|
|
|
0.710 |
GeneticVariation |
BEFREE |
As this mutation is consistent with the clinical manifestations of CF and no other mutations were detected after scanning the gene sequence, we suggest that the CF phenotype is caused by compound heterozygosity for c.865A>T and c.3651_3652insAAAT.
|
26471113 |
2017 |
rs74551128
|
|
|
0.880 |
GeneticVariation |
BEFREE |
Because most commercial kits and laboratory-developed tests for CF c</span>arrier screening involve a short amplicon encompassing this mutation, this finding suggests that individuals with the c.1364C>A (p.A455E) mutation may require further investigation to avoid a false assignment of CF carrier status.
|
25956447 |
2015 |
rs74571530
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Both patients with the complex allele F508C-S1251N are carrying delta F508 on the other CF chromosome and are suffering from severe pulmonary and gastrointestinal CF disease.
|
1284535 |
1992 |
rs74503330
|
|
|
0.820 |
GeneticVariation |
BEFREE |
Both patients with the complex allele F508C-S1251N are carrying delta F508 on the other CF chromosome and are suffering from severe pulmonary and gastrointestinal CF disease.
|
1284535 |
1992 |
rs74767530
|
|
|
0.710 |
GeneticVariation |
BEFREE |
By comparing the data obtained from polyps deriving from non-CF subjects and a CF patient homozygous for dF508 mutation, it is shown that no reduction of CF gene expression is evident in R1162X respiratory tissue.
|
7504691 |
1993 |
rs77010898
|
|
|
0.800 |
GeneticVariation |
BEFREE |
By this procedure, it is possible to perform real-time monitoring of hybridization between target single stranded PCR products obtained by using as substrates DNA isolated from normal or heterozygous subjects, and homozygous W1282X CF samples and oligonucleotide probes, therefore enabling a one-step, non-radioactive protocol to perform diagnosis.
|
11438995 |
2001 |
rs121908803
|
|
|
0.820 |
GeneticVariation |
BEFREE |
Case report of 1 patient with long-standing chronic sinus disease and a new diagnosis of CF with a mild mutation (P205S) and a severe mutation (G551D).
|
25363320 |
2015 |
rs75527207
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Case report of 1 patient with long-standing chronic sinus disease and a new diagnosis of CF with a mild mutation (P205S) and a severe mutation (G551D).
|
25363320 |
2015 |
rs397508310
|
|
|
0.710 |
GeneticVariation |
BEFREE |
CFTR H609R mutation in Ecuadorian patients with cystic fibrosis.
|
19457724 |
2009 |
rs397508462
|
|
|
0.730 |
GeneticVariation |
BEFREE |
CFTR gene analysis in cystic fibrosis patients: detection of 91% of molecular defects and identification of the novel mutation D979V.
|
9401110 |
1997 |
rs74551128
|
|
|
0.880 |
GeneticVariation |
BEFREE |
CFTR molecular testing detected two mutations F508del and A455E corresponding to a cystic fibrosis genotype.
|
22390181 |
2012 |
rs74597325
|
|
|
0.800 |
GeneticVariation |
BEFREE |
CFTR transcripts are undetectable in lymphocytes and respiratory epithelial cells of a CF patient homozygous for the nonsense mutation R553X.
|
7693946 |
1993 |
rs75527207
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.
|
31604026 |
2020 |
rs75527207
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Changes of CFTR functional measurements and clinical improvements in cystic fibrosis patients with non p.Gly551Asp gating mutations treated with ivacaftor.
|
27659740 |
2017 |
rs397508498
|
|
|
0.710 |
GeneticVariation |
BEFREE |
Children carrying Unknown mutations 2215insG with D836Y, and T1036N had early and classical CF phenotype, while others carrying 1525-42G>A, L320V, L967S, R170H, and 296+28A>G had a benign clinical presentation, suggesting that these are non-CF causing.
|
27214204 |
2016 |
rs193922500
|
|
|
0.710 |
GeneticVariation |
BEFREE |
Clinical evidence that V456A is a Cystic Fibrosis causing mutation in South Asians.
|
22395041 |
2012 |
rs75527207
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Clinical studies in patients with cystic fibrosis and G551D-CFTR showed that the group treated with ivacaftor had improved clinical outcomes.
|
25755212 |
2015 |
rs75527207
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Clinical trials have shown an improvement in lung function, weight and CF pulmonary exacerbation in adults with CFTR-G551D</span> leading to the approval of ivacaftor as a novel CF therapy [1].
|
25698453 |
2015 |
rs80034486
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Co-potentiator efficacy was confirmed in primary human bronchial epithelial cell cultures generated from a N1303K homozygous CF subject.
|
31776420 |
2019 |
rs397508638
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Co-potentiator efficacy was confirmed in primary human bronchial epithelial cell cultures generated from a N1303K homozygous CF subject.
|
31776420 |
2019 |